These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 12759234)

  • 1. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
    Fan X; Wang Y; Kratz J; Brat DJ; Robitaille Y; Moghrabi A; Perlman EJ; Dang CV; Burger PC; Eberhart CG
    Am J Pathol; 2003 Jun; 162(6):1763-9. PubMed ID: 12759234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
    Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
    Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
    Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
    Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
    Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
    Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
    Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
    J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
    Wolter M; Reifenberger J; Sommer C; Ruzicka T; Reifenberger G
    Cancer Res; 1997 Jul; 57(13):2581-5. PubMed ID: 9205058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
    Mod Pathol; 2001 Nov; 14(11):1073-8. PubMed ID: 11706066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.
    Schrader M; Burger AM; Müller M; Krause H; Straub B; Smith GL; Newlands ES; Miller K
    Oncol Rep; 2002; 9(5):1097-105. PubMed ID: 12168080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
    Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
    Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaphase and array comparative genomic hybridization: unique copy number changes and gene amplification of medulloblastomas in South America.
    Yoshimoto M; Bayani J; Nuin PA; Silva NS; Cavalheiro S; Stavale JN; Andrade JA; Zielenska M; Squire JA; de Toledo SR
    Cancer Genet Cytogenet; 2006 Oct; 170(1):40-7. PubMed ID: 16965953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.
    Kotoula V; Barbanis S; Nikolakaki E; Koufoyannis D; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2004 May; 107(5):443-51. PubMed ID: 14986029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.
    Krams M; Claviez A; Heidorn K; Krupp G; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2001 Nov; 159(5):1925-32. PubMed ID: 11696453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas.
    Pfister S; Remke M; Toedt G; Werft W; Benner A; Mendrzyk F; Wittmann A; Devens F; von Hoff K; Rutkowski S; Kulozik A; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    Genes Chromosomes Cancer; 2007 Sep; 46(9):839-51. PubMed ID: 17592618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the hTERT expression in squamous cell cervical carcinoma is not associated with gene amplification.
    Anedchenko E; Oparina N; Dmitriev A; Krasnov G; Pavlova L; Alexandrova N; Kisseljov F; Senchenko V
    Oncol Rep; 2008 Aug; 20(2):469-74. PubMed ID: 18636213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
    Yano Y; Yoshida K; Osaki A; Toge T; Tahara H; Ide T; Yasui W
    Anticancer Res; 2002; 22(6C):4101-7. PubMed ID: 12553039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.